Point72 Europe (London) LLP Acadia Pharmaceuticals Inc Transaction History
Point72 Europe (London) LLP
- $1.62 Billion
- Q4 2024
A detailed history of Point72 Europe (London) LLP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Point72 Europe (London) LLP holds 173,155 shares of ACAD stock, worth $3.41 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
173,155Holding current value
$3.41 Million% of portfolio
0.2%Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
316Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$843 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$274 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$237 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$171 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$144 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.18B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...